Salute e Benessere

Multimodal Imaging Market to Reach $7.9 Billion, Globally, by 2032 at 6.1% CAGR…

Request Sample of the Report on Multimodal Imaging Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/6621 Request Sample of the Report on Multimodal Imaging Market Forecast 2032-https://www.alliedmarketresearch.com/request-sample/6621 Prime determinants of growth Rise in prevalence of chronic diseases such as cancer, rise in advancements in diagnostic imaging modalities, and growing application of multimodal imaging systems drive the growth of the...
PR Newswire
29/11/2023

Health and Wellness Market Size Could Reach USD 8,945.30 billion by 2032 |…

Forecasted Health and Wellness Market Size 2022 to 2032 Forecasted Health and Wellness Market Size 2022 to 2032 The term "health and wellness" refers to a wide range of social, psychological, and physical aspects that affect an individual's general state of well-being. To be healthy, one must identify and manage illnesses, evaluate one's risk of contracting a certain condition, and treat unintentional injuries. The Full Report is Readily Available | Download the Sample Pages of...
PR Newswire
29/11/2023

Research from Philips and Vanderbilt shows how decarbonizing healthcare also…

Amsterdam, the Netherlands and Chicago, USA –Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, and Vanderbilt University Medical Center (VUMC), home to top-ranked adult and pediatric hospitals in the Southeastern U.S., today announced initial results of a research collaboration to decarbonize the health system's radiology department. The project, which was initially announced in May 2023, shows that sustainable initiatives can be both environmentally...
Nasdaq GlobeNewswire
29/11/2023

Amsterdam to Welcome the European Compliance & Ethics Community

Planned session topics include: Planned session topics include: In addition to traditional corporate compliance and ethics topics, the ECEI will also offer sessions relating to healthcare compliance. The healthcare offerings will provide valuable information for professionals who need guidance on establishing, maintaining, and mitigating risk for compliance programs specifically within healthcare settings. To learn more about this year's ECEI, visitwww.corporatecompliance.org/2024ECEI...
PR Newswire
29/11/2023

AI Innovation for automated Detection and Classification of osteoporotic…

Understanding the Osteoporosis Challenge Understanding the Osteoporosis Challenge "Together with expert clinicians, UCB developed this deep-learning computational model that can detect vertebral compression fractures on CT scans. ImageBiopsy Lab as a musculoskeletal (MSK) radiology AI company has refined the technology and is now ready to integrate it into clinical care. Given that 80% of fragility fractures today remain undiagnosed and untreated, we're excited about the potential of IB...
PR Newswire
29/11/2023

uniQure Announces FDA Clearance of Investigational New Drug Application…

Patient enrollment expected to begin in first half of 2024 uniQureN.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for AMT-191, the Company's gene therapy candidate forFabry disease. AMT-191 comprises an AAV5 vector that delivers an α-galactosidase A (GLA) transgene designed to target the...
Nasdaq GlobeNewswire
29/11/2023

Hevolution Foundation Convenes 2000 Delegates for Inaugural Global Healthspan…

The opening of the two-day event saw action-based conversations around catalyzing research, entrepreneurship, investment, and international collaboration in the emerging field of healthspan science. Sessions explored the societal impacts of population aging, the pharmaceutical ecosystem, and next-generation medicine, featuring speakers from institutions such as 5am Ventures, Eli Lilly, GSK, Harvard University, Lifera, Mayo Clinic, Milken Institute, Ministry of Health for Saudi Arabia, National…
PR Newswire
29/11/2023

Genpax named 2023 winners of the IET Excellence and Innovation Award for Health…

Dr Nigel Saunders, Chief Scientific Officer and co-founder, said, "I am delighted that IDEM has been recognised for its innovation. We look forward to making a difference in Infection Prevention and Control in Healthcare and beyond." DrNigel Saunders, Chief Scientific Officer and co-founder, said, "I am delighted that IDEM has been recognised for its innovation. We look forward to making a difference in Infection Prevention and Control in Healthcare and beyond." Ed Almond…
PR Newswire
29/11/2023

Advanced Dental Digital and Robotics Solutions Market worth $7.95 Bn by 2031 -…

Advanced Dental Digital and Robotics Solutions Market Report Scope Advanced Dental Digital and Robotics Solutions Market Report Scope Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/2232 Advanced Dental Digital and Robotics Solutions integrate advanced technologies, such as digital imaging, computer-aided design and manufacturing, robotics, and other digital solutions in dentistry. Dental items include equipment and consumables that aid in the...
PR Newswire
29/11/2023

75 Percent of Azerbaijani Women Know Little About Thalassemia Health Risks: BGI…

This report shows Azerbaijan has a higher percentage of women (75.2%) relative to global average (70.5%) that know little about thalassemia health risks and treatment. Yet, Azerbaijan's compulsory premarital hemoglobinopathy screening program applies to every couple, resulting in increased female participation in this screening process. Dr. Agha Rza Aghayev noted that: "From my personal perspective, there has been a notable rise in women's awareness regarding the preventability of genetic…
PR Newswire
29/11/2023

Photocure Partner Asieris announces New Drug Application acceptance for…

The highly statistically significant results corroborate the findings of Photocure's own randomized controlled trials (RCTs) that demonstrated the clinical benefits of Hexvix BLC over WLC, specifically superior tumor detection and a favorable tolerability profile with no serious adverse events. Moreover, Asieris' Phase III Hexvix trial is the first RCT that was conducted with high definition 4K blue light capital equipment. The highly statistically significant results corroborate the findings...
PR Newswire
29/11/2023

DP WORLD: RAISING TEMPERATURE OF FROZEN FOODS BY JUST THREE DEGREES FROM -18°C…

A move to -15°C could make a significant environmental impact with no compromise on food safety or quality, the study found. A move to -15°C could make a significant environmental impact with no compromise on food safety or quality, the study found. The experts, from theParis -based International Institute of Refrigeration, theUniversity of Birminghamand London South Bank University, among others, found that the small change could: The research was supported by the leading...
PR Newswire
29/11/2023

Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for…

The study, assessing pharmacokinetics, safety, and tolerability of AVT05 compared to Simponi® (golimumab) in healthy adult subjects, met its primary endpointAlvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today positive top-line results from a pharmacokinetic study for AVT05, a biosimilar candidate to Simponi® and Simponi Aria® (golimumab). The study, which assessed the...
Nasdaq GlobeNewswire
29/11/2023

Smart or AI In-Vitro Diagnostics Market to Record an Exponential CAGR by 2031 -…

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1773 In recent times, there has been a recent uprise in the prevalence of chronic diseases, along with expanded research and development for the use of IVDs for more accurate and speedy diagnosis. Additionally, the rising utilization of pandemic-required breakthroughs, including digital pathology and remote collection, is anticipated to propel market growth. It is projected that such technological...
PR Newswire
29/11/2023

Addex Reports Q3 2023 Financial Results and Provides Corporate Update

ADX71149 Phase 2 epilepsy clinical study completes recruitment of patients, with top line results expected in Q2 2024mGlu2 NAM cognition program receives a €4 million Eurostars grantCHF 4.8M ($5.2M) of cash and cash equivalents at September 30, 2023 Ad Hoc Announcement Pursuant to Art. 53 LRGeneva, Switzerland, November 29, 2023-Addex Therapeutics(SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery...
Nasdaq GlobeNewswire
29/11/2023

Sequana Medical announces positive data from non-randomized cohort in US Phase…

PRESS RELEASE REGULATED INFORMATION – INSIDE INFORMATION29 November 2023, 07:00 am CETData from all three patients in non-randomized cohort treated with DSR 2.0 indicate safe and effective maintenance of euvolemia without the need for loop diuretics,considerable benefit in cardiorenal status and dramatic improvement in diuretic response and loop diuretic requirements up to 11 weeks post DSR treatmentDSMB ireview planned for early Q1 2024 to approve...
Nasdaq GlobeNewswire
29/11/2023

"Anti-Choke Mug" - Chula Innovation for Neuro Patients to Drink Water…

"When patients with difficulty swallowing and are prone to choking come to see the doctor, the doctor would advise them to eat slowly, drink slowly, bend their neck, then swallow mindfully and practice their neck muscles regularly. This is easier said than done, as less than half of the patients can do this because we often eat and drink the way we're used to, so much so that we run the risk of choking," reflected Professor Roongroj Bhidayasiri, M.D., a neurology specialist, and head…
PR Newswire
29/11/2023

DN Solutions Opens First Technical Center in Europe: Strengthening Pre-sales…

Various automation solutions and machining demonstrations Various automation solutions and machining demonstrations The Center, spanning an impressive 1,000 square meters, features a range of cutting-edge facilities. At the opening ceremony, the company gave visitors live demonstrations of twelve ultra-modern CNC machines in this area. The focus was on advanced automation solutions in collaboration with various specialized automation companies. DN Solutions also presented...
PR Newswire
29/11/2023

Metastatic Non-small Cell Lung Cancer Market Forecast Analysis and with Focus on…

Metastatic Non-small Cell Lung Cancer Market Report Key Takeaways Dive deeper for rich insights into the Metastatic NSCLC Market Outlook Metastatic Non-small Cell Lung Cancer: Overview and Treatment NSCLC is the most common type of lung cancer, accounting for80-85%of all lung cancer diagnoses. Early diagnosis offers the best prognosis for NSCLC. However, NSCLC and other lung cancers can be difficult to diagnose because, often, these cancers have symptoms that are...
PR Newswire
28/11/2023

Navigating the Evolving Market Dynamics of Bone Sarcoma: A Comprehensive…

DelveInsight has recently released a series of epidemiology-based market reports focusing on benign bone sarcoma includingOsteosarcoma Market Report, Ewing Sarcoma Market Report, and Chondrosarcoma Market Report. These reports include a comprehensive understanding of current treatment practices, historical and forecasted patient pool, emerging drugs, market share of individual therapies, and historical and forecasted market size from 2019 to 2032 segmented into 7MM [ the United...
PR Newswire
28/11/2023

Nyxoah Strengthens its Executive Leadership Team

Nyxoah Strengthens its Executive Leadership Team Francis Kim appointed as Chief Regulatory and Quality OfficerMont-Saint-Guibert, Belgium – November 28, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the appointment of Francis Kim as Chief Regulatory and Quality Officer...
Nasdaq GlobeNewswire
28/11/2023

Mayo Clinic Board of Trustees approves plans to transform healthcare, improve…

"Mayo Clinic has a 160-year history of leading the world in healthcare innovation. As part of our Bold. Forward. strategy, we have a once-in-three generations opportunity to redefine the future of healthcare," says Gianrico Farrugia, M.D., president and CEO, Mayo Clinic. "Bold. Forward. Unbound. in Rochester will enable transformation by blurring the lines across hospital, clinic and digital care to help our teams anticipate our patients' needs, accelerate more cures and greater…
PR Newswire
28/11/2023

Alvotech Reports Financial Results for First Nine Months of 2023 and Provides…

Product revenue for the nine months of 2023 increased to $29.8 million, compared to $11.1 million for the same period in 2022Marketing authorization was received for AVT04 in Canada and Japan, the first for a biosimilar to Stelara® (ustekinumab)The European Medicines Agency proposed market authorization for AVT04 in the 30 member states of the European Economic Area, pending a final decision by the European CommissionApprovability of AVT02 and AVT04 in the U.S. now pending...
Nasdaq GlobeNewswire
28/11/2023

AB Science will host a live webcast on Thursday November 30, 2023, from 3pm to…

PRESS RELEASEAB SCIENCE WILL HOST A LIVE WEBCAST ON THE MASITINIB DEVELOPMENT PROGRAM IN SICKLE CELL DISEASE ON THURSDAY NOVEMBER 30, 2023, FROM 3PM TO 4PM CETParis, 28 november, 2023, 7.15pm CETAB Science SA(Euronext – FR0010557264 – AB) will host a live webcast on Thursday November 30, 2023, from 3pm to 4pm CET, to present the masitinib development program in sickle cell disease. This live webcast will provide further details on: Sickle cell disease and the scientific...
Nasdaq GlobeNewswire
28/11/2023
Altri  Comunicati